(Q42274386)

English

Acadesine: a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. Multinational Acadesine Study Group

scientific article published on October 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Acadesine: a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. Multinational Acadesine Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

multicenter clinical trial

0 references

coronary artery bypass surgery

1 reference

based on heuristic

inferred from title

author name string

Menasché P

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jamieson WR

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Flameng W

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Davies MK

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

1 October 1995

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

The Journal of Thoracic and Cardiovascular Surgery

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

4 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1096-1106

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

The changing profile of the patient undergoing coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Initial report of the Veterans Administration Preoperative Risk Assessment Study for Cardiac Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Mortality of coronary artery bypass grafting before and after the advent of angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Mortality after coronary angioplasty and coronary artery bypass surgery (the national Medicare experience)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Perioperative myocardial infarction after coronary artery bypass surgery. Clinical significance and approach to risk stratification

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Further observations on perioperative myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Quantitation of CK-MB release: diagnostic utility in coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Perioperative myocardial infarction: a diagnostic dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Changes in Left Ventricular Performance Related to Perioperative Myocardial Infarction in Coronary Artery Bypass Graft Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Interpretation of changes in the activity of creatine kinase MB isoenzyme in serum after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Perioperative myocardial infarction: late clinical course after coronary artery bypass surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

The value of serum CK-MB and myoglobin measurements for assessing perioperative myocardial infarction after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Myocardial infarction determined by technetium-99m pyrophosphate single-photon tomography complicating elective coronary artery bypass grafting for angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Adenosine and the anti-infarct effects of preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Acadesine (AICA-riboside) improves postischemic cardiac recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Changes in serum CK-MB mass after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Sample size determinants for r X c comparative trials

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Adenosine--a cardioprotective and therapeutic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

Myocardial preconditioning. Part of the adenosine revival

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

New Q waves after aortocoronary bypass surgery. Unmasking of an old infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

New intraoperative cardioprotective strategies for myocardial protection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-5223(05)80179-5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42274386&oldid=2172986176"